Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To demonstrate the efficacy of topical 0.002% mitomycin C (MMC) as an adjunctive and alternative treatment in primary and recurrent conjunctival-corneal intraepithelial neoplasia (CCIN) and squamous cell carcinoma (SCC).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Cornea

Title: Cornea

ISSN: 0277-3740

ISSN (Print): 0277-3740

Publication date (Electronic): May 2005

Volume: 24

Issue: 4

Affiliations

[1 ] Department of Ophthalmology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand. sippb@mahidol.ac.th

Article

Publisher Item ID: 00003226-200505000-00014

DOI: 10.1016/j.ajo.2005.07.014

PubMed ID: 15829803

SO-VID: d0f2fdf9-94db-451b-81d4-20b472cf35d5

History

Data availability:

Comments

Comment on this article

scite_

Cited by 10

See all cited by